Log In

Forgot Password?
Create New Account

Loading... please wait

2023 Annual Meeting | IS4 - Invited Science: Sleep

Wednesday 04/26/23
03:30 PM - 05:30 PM EST Add To Calendar
This program will be presented both in-person and online
This program will be available in the meeting's On Demand product.
Invited Science
Temitayo Oyegbile-Chidi, MD, PhD, FAAN, Romy Hoque, MD
Sleep
This session will highlight cutting edge science of hot topics in sleep in partnership with the Sleep Research Society/American Academy for Sleep Medicine.
2.00 CME credits
Event Timeline
03:30 PM - 03:50 PM EST Speaker Associations of Objective Sleep Parameters and Gray Matter Microstructure in Community Dwelling Cognitive Normal Older Adults
Omonigho M. Bubu, MD, PhD
03:50 PM - 04:10 PM EST Speaker Sleep Duration and Brain MRI Biomarkers: Results from SOL-INCA MRI Study
Alberto Ramos, MD, FAAN
04:10 PM - 04:30 PM EST Speaker Associations Between Alzheimer’s Disease Pathology and the Psychomotor Vigilance Task in Cognitively Unimpaired Adults With and Without Obstructive Sleep Apnea
David Plante
04:30 PM - 04:50 PM EST Speaker Actigraphy-based and Self-reported Sleep Quality and Cognitive Function in Midlife
Yue Leng
04:50 PM - 05:10 PM EST Speaker Early Sleep-disordered Breathing in Moderate-to-severe Traumatic Brain Injury (TBI) is Linked with Chronic Pain Status at Long-term Follow-up: A TBI Model Systems Study
Aaron Martin
05:10 PM - 05:30 PM EST Speaker Sex Differences in Sleep Quality and Biomarker Levels in Service Members and Veterans with Chronic Mild Traumatic Brain Injury
Vivian d. Guedes
Faculty Disclosures
Temitayo Oyegbile-Chidi, MD, PhD, FAAN Dr. Oyegbile-Chidi has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Spectrum. Dr. Oyegbile-Chidi has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for UC Regents. The institution of Dr. Oyegbile-Chidi has received research support from NIH.
Romy Hoque, MD Dr. Hoque has nothing to disclose.
Omonigho M. Bubu, MD, PhD Dr. Bubu has nothing to disclose.
Alberto Ramos, MD, FAAN Dr. Ramos has received personal compensation in the range of $500-$4,999 for serving as a Consultant for One Care Media, LLC. Dr. Ramos has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for National Heart, Lung and Blood Institute . The institution of Dr. Ramos has received research support from Axsome pharmaceutical. The institution of Dr. Ramos has received research support from NIH. The institution of Dr. Ramos has received research support from National Institutes of Aging/NIH. Dr. Ramos has received personal compensation in the range of $500-$4,999 for serving as a Clinical Advisor with Neurogeneces, Inc. Dr. Ramos has a non-compensated relationship as a Editorial Board with Chest Scientific Journal that is relevant to AAN interests or activities.
David Plante David Plante has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz Pharmaceuticals. David Plante has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Harmony Biosciences. David Plante has received personal compensation in the range of $0-$499 for serving as a Consultant for Aditum Bio. David Plante has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jazz Pharmaceuticals. David Plante has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer. David Plante has received intellectual property interests from a discovery or technology relating to health care. David Plante has received publishing royalties from a publication relating to health care.
Yue Leng The institution of Yue Leng has received research support from NIH.
Aaron Martin Aaron Martin has nothing to disclose.
Vivian d. Guedes Vivian de Alvarenga Guedes has nothing to disclose.